AI assistant
Sending…
MILESTONE SCIENTIFIC INC. — Director's Dealing 2015
Mar 24, 2015
34735_dirs_2015-03-24_17c9f751-10ff-4a04-adfc-57beab788a45.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MILESTONE SCIENTIFIC INC. (MLSS.OB)
CIK: 0000855683
Period of Report: 2014-11-20
Reporting Person: OSSER LEONARD (Director, CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-20 | Options to purchase common stock | $2.38 | A | 185185 | Acquired | 2019-11-20 | Common Stock (185185) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.001 par value | 2792090 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to purchase common stock | $1.49 | 2019-11-01 | Common Stock (73333) | 73333 | Direct |
| Options to purchase common stock | $1.65 | 2018-12-31 | Common Stock (248448) | 248448 | Direct |
| Options to purchase common stock | $0.75 | 2017-01-09 | Common Stock (133334) | 133334 | Direct |
Footnotes
F1: Includes 706,717 shares of common stock issuable at the termination of employment.
F2: These options are exercisable as follows: (i) immediately for 137,972 and (ii) for an additional 55,238 on each of 12/31/15 and 12/31/16.
F3: Immediately exercisable.
F4: These options are exercisable as follows: (i) for 61,728 shares on the date of grant (11-20-14) and (ii) for an additional 1/3 of the 123,457 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.
F5: Not applicable.
More from MILESTONE SCIENTIFIC INC.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
May 5
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 10
Regulatory Filings
2026
Feb 4